Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis?

References

• Filippi M, Bar-Or A, Piehl F, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1):43.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Allahabadi NS, Sadeghi M, et al. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015. BMC Neurol. 2018;18(1):15.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Heydarpour P, Minagar A, et al. Multiple sclerosis epidemiology in East Asia, South East Asia and South Asia: a systematic review. Neuroepidemiology. 2016; 46(3):209–221.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Molazadeh N, Moghadasi AN, et al. The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran. Mult Scler Relat Disord. 2018; 25:143.
   PubMed Web of Science ®Google Scholar
• Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell J. 2017;19(1):1–10.
   PubMed Web of Science ®Google Scholar
• Owji M, Ashraf-Ganjouei A, Sahraian MA, et al. The relationship between cognitive function and body mass index in multiple sclerosis patients. Mult Scler Relat Disord. 2019;32:37–40.
   PubMed Web of Science ®Google Scholar
• Macías Islas MÁ, Ciampi E. Assessment and impact of cognitive impairment in multiple sclerosis: an overview. Biomedicines. 2019;7(1):22. pii:
   PubMed Web of Science ®Google Scholar
• Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol. 2009;66(3):300–305.
   PubMed Web of Science ®Google Scholar
• Solomon A, Kåreholt I, Ngandu T, et al. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology. 2007; 68(10):751–756.
   PubMed Web of Science ®Google Scholar
• van Vliet P. Cholesterol and late-life cognitive decline. J Alzheimer's Dis. 2012;30(s2):S147–S62.
   PubMed Web of Science ®Google Scholar
• Gafson AR, Thorne T, McKechnie CIJ, et al. Lipoprotein markers associated with disability from multiple sclerosis. Sci Rep. 2018;8(1):17026.
   PubMed Web of Science ®Google Scholar
• Tettey P, Simpson S, Jr, Taylor B, et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. Mult Scler. 2014;20(13):1737–1744.
   PubMed Web of Science ®Google Scholar
• Reiner Z, Catapano AL, De Backer G, et al. The European Association for Cardiovascular Prevention & Rehabilitation, and the ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011; 32:1769–1818.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173.
   PubMed Web of Science ®Google Scholar
• Ng TP, Feng L, Lim WS, et al. Montreal Cognitive Assessment for screening mild cognitive impairment: variations in test performance and scores by education in Singapore. Dement Geriatr Cogn Disord. 2015;39(3-4):176–185.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Publishing. 2013.
   Google Scholar
• Meyer-Moock S, Feng YS, Maeurer M, et al. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol. 2014;14:58.
   PubMed Web of Science ®Google Scholar
• Noori H, Gheini MR, Rezaeimanesh N, et al. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients. Mult Scler Relat Disord. 2019; 36:101415
   PubMed Web of Science ®Google Scholar
• He Q, Li Q, Zhao J, et al. Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study. Lipids Health Dis. 2016;15(1):146.
   PubMed Web of Science ®Google Scholar
• McNeilly AD, Williamson R, Sutherland C, et al. High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav Brain Res. 2011;217(1):134–141.
   PubMed Web of Science ®Google Scholar
• Valladolid-Acebes I, Stucchi P, Cano V, et al. High-fat diets impair spatial learning in the radial-arm maze in mice. Neurobiol Learn Mem. 2011; 95(1):80–85.
   PubMed Web of Science ®Google Scholar
• Hoane MR, Swan AA, Heck SE. The effects of a high-fat sucrose diet on functional outcome following cortical contusion injury in the rat. Behav Brain Res. 2011; 223(1):119–124.
   PubMed Web of Science ®Google Scholar
• Thirumangalakudi L, Prakasam A, Zhang R, et al. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem. 2008;106(1):475–485.
   PubMed Web of Science ®Google Scholar
• Giubilei F, Antonini G, Di Legge S, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand. 2002;106(2):109–112.
   PubMed Web of Science ®Google Scholar
• Marrie RA, Rudick R, Horwitz R, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology. 2010;74(13):1041–1047.
   PubMed Web of Science ®Google Scholar
• Weinstock-Guttman B, Zivadinov R, Mahfooz N, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation. 2011;8(1):127.
   PubMed Web of Science ®Google Scholar
• O'Brien PD, Hinder LM, Callaghan BC, et al. Neurological consequences of obesity. Lancet Neurol. 2017;16(6):465–477.
   PubMed Web of Science ®Google Scholar
• Anstey KJ, Cherbuin N, Budge M, et al. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011;12(5):e426–e437.
   PubMed Web of Science ®Google Scholar
• Loef M, Walach H. Midlife obesity and dementia: Meta-analysis and adjusted forecast of dementia prevalence in the United States and China. Obesity (Silver Spring)). 2013;21(1):E51–E55.
   PubMed Web of Science ®Google Scholar
• Sabia S, Kivimaki M, Shipley MJ, et al. Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. Am J Clin Nutr. 2009;89(2):601–607.
   PubMed Web of Science ®Google Scholar
• Nameni G, Farhangi MA, Hajiluian G, et al. Insulin deficiency: a possible link between obesity and cognitive function. Int J Dev Neurosci. 2017;59:15–20.
   PubMed Web of Science ®Google Scholar
• Strachan MW, Reynolds RM, Marioni RE, et al. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol. 2011;7(2):108–114.
   PubMed Web of Science ®Google Scholar
• Cunningham C, Campion S, Lunnon K, et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry. 2009;65(4):304–312.
   PubMed Web of Science ®Google Scholar
• Willette AA, Kapogiannis D. Does the brain shrink as the waist expands? Ageing Res. Rev. 2015;20:86–97.
   PubMed Web of Science ®Google Scholar
• Karastergiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol. 2010;318(1-2):69–78.
   PubMed Web of Science ®Google Scholar
• Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29(8):439–493.
   PubMed Web of Science ®Google Scholar
• Stępień M, Stępień A, Wlazeł RN, et al. Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study. Lipids Health Dis. 2014;13(1):29.
   PubMed Web of Science ®Google Scholar